Taiwan FDA registration 713f1b9f651168ca2f1de6ba097e46f7
"Xinkehua" Jouris Hepatitis C Virus Antibody Test Reagent (4th Generation)
TW: “新科化”妙芮絲C型肝炎病毒抗體檢驗試劑(第四代)
Taiwan·Risk Class 3·DiaSorin South Africa (Pty) Ltd.·Registered Jul 18, 2012 – Aug 12, 2017CancelledRegistration details
- Analysis ID
- 713f1b9f651168ca2f1de6ba097e46f7
- Customs Code
- DHA00602380401
Company information
- Manufacturer
- DiaSorin South Africa (Pty) Ltd.
- Manufacturer Country
- South Africa
- Authorized Representative
- NEW SCIENTIFIC EQUIPMENT CO., LTD.
Product details
- Intended Use
- Enzyme immunoassay is used to sexually test human serum or plasma for antibodies to hepatitis C virus.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.4020 Analysis of specific tests
- Import Information
- import
Dates and status
- Registration Date
- Jul 18, 2012
- Expiry Date
- Aug 12, 2017
- Cancellation Date
- Nov 15, 2019
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Xinkehua" Jouris Hepatitis C Virus Antibody Test Reagent (4th Generation) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 713f1b9f651168ca2f1de6ba097e46f7 and manufactured by DiaSorin South Africa (Pty) Ltd.. The authorized representative in Taiwan is NEW SCIENTIFIC EQUIPMENT CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices